J.P. Morgan increases holdings in Asymchem Laboratories (06821) by approximately 227,400 shares at a price of around 58.84 Hong Kong dollars per share.
On February 20th, JPMorgan Chase increased its holdings of Kellyeng (06821) by 227,356 shares, with a share price of 58.8364 Hong Kong dollars, totaling approximately 13.3768 million Hong Kong dollars.
According to the latest data from the Hong Kong Stock Exchange, on February 20, J.P. Morgan increased its holdings of Asymchem Laboratories (06821) by 227,356 shares, at a price of 58.8364 Hong Kong dollars per share, totaling approximately 13.3768 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 1.4518 million shares, with a latest shareholding percentage of 5.26%.
Related Articles
Nanjing King-Friend Biochemical Pharmaceutical (603707.SH) subsidiary obtains US FDA registration approval for additional manufacturing site for amikacin sulfate injection
Jinling Pharmaceutical (000919.SZ) subsidiary's arotinolol hydrochloride API approved for marketing.
Morgan Stanley: HSBC HOLDINGS (00005) and STANCHART (02888) valuations are more attractive than their Singapore peers.
Nanjing King-Friend Biochemical Pharmaceutical (603707.SH) subsidiary obtains US FDA registration approval for additional manufacturing site for amikacin sulfate injection
Jinling Pharmaceutical (000919.SZ) subsidiary's arotinolol hydrochloride API approved for marketing.
Morgan Stanley: HSBC HOLDINGS (00005) and STANCHART (02888) valuations are more attractive than their Singapore peers.
